Canadian drug developer Medicago says a combination of its experimental COVID-19 vaccine and GlaxoSmithKline’s vaccine booster produced an antibody response in a Phase 1 clinical trial.
Posted in
#canadahealth #canadahealthy #canadalistings #canadastory #canadianhealth Health Search Canada Online Listing

